1. Home
  2. MDWD vs SRI Comparison

MDWD vs SRI Comparison

Compare MDWD & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • SRI
  • Stock Information
  • Founded
  • MDWD 2000
  • SRI 1965
  • Country
  • MDWD Israel
  • SRI United States
  • Employees
  • MDWD N/A
  • SRI N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • SRI Auto Parts:O.E.M.
  • Sector
  • MDWD Health Care
  • SRI Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • SRI Nasdaq
  • Market Cap
  • MDWD 195.2M
  • SRI 172.9M
  • IPO Year
  • MDWD 2014
  • SRI 1997
  • Fundamental
  • Price
  • MDWD $17.66
  • SRI $6.17
  • Analyst Decision
  • MDWD Strong Buy
  • SRI Buy
  • Analyst Count
  • MDWD 2
  • SRI 1
  • Target Price
  • MDWD $35.00
  • SRI $16.00
  • AVG Volume (30 Days)
  • MDWD 60.7K
  • SRI 191.8K
  • Earning Date
  • MDWD 11-20-2025
  • SRI 11-05-2025
  • Dividend Yield
  • MDWD N/A
  • SRI N/A
  • EPS Growth
  • MDWD N/A
  • SRI N/A
  • EPS
  • MDWD N/A
  • SRI N/A
  • Revenue
  • MDWD $19,858,000.00
  • SRI $874,357,000.00
  • Revenue This Year
  • MDWD $21.39
  • SRI N/A
  • Revenue Next Year
  • MDWD $23.01
  • SRI $7.68
  • P/E Ratio
  • MDWD N/A
  • SRI N/A
  • Revenue Growth
  • MDWD N/A
  • SRI N/A
  • 52 Week Low
  • MDWD $14.14
  • SRI $3.54
  • 52 Week High
  • MDWD $22.51
  • SRI $9.10
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 42.31
  • SRI 38.39
  • Support Level
  • MDWD $17.50
  • SRI $6.55
  • Resistance Level
  • MDWD $18.58
  • SRI $7.06
  • Average True Range (ATR)
  • MDWD 0.60
  • SRI 0.41
  • MACD
  • MDWD -0.13
  • SRI -0.07
  • Stochastic Oscillator
  • MDWD 2.88
  • SRI 26.49

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: